{"id":41078,"date":"2026-06-25T07:06:09","date_gmt":"2026-06-25T07:06:09","guid":{"rendered":"https:\/\/www.europesays.com\/france\/41078\/"},"modified":"2026-06-25T07:06:09","modified_gmt":"2026-06-25T07:06:09","slug":"press-release-sanofi-foundation-opens-new-chapter-centered-on-future-generations","status":"publish","type":"post","link":"https:\/\/www.europesays.com\/france\/41078\/","title":{"rendered":"Press Release: Sanofi Foundation opens new chapter centered on future generations"},"content":{"rendered":"

Sanofi Foundation opens new chapter centered on future generations<\/p>\n

Paris, June 25, 2026.\u00a0The Sanofi Foundation is opening\u00a0a new chapter with a strengthened commitment to children and young people, particularly those living with serious diseases.\u00a0Through the Foundation, Sanofi extends its commitment to improving people’s lives beyond healthcare by supporting younger generations facing some of today’s most pressing health,\u00a0climate, and humanitarian challenges.<\/p>\n

“The challenges facing younger generations today extend far beyond access to healthcare alone. By strengthening the focus of the Sanofi Foundation, we are reaffirming our conviction that companies have a role to play in helping create the conditions for every child and young person to thrive, contribute and look to the future with confidence,\u201d\u00a0said\u00a0Fr\u00e9d\u00e9ric\u00a0Oud\u00e9a,\u00a0Chairman of the Board of Directors Sanofi\u00a0Foundation,\u00a0and\u00a0Chairman of the Board of Directors Sanofi<\/p>\n

At the heart of this new direction is a simple belief:\u00a0no child should be defined or limited by a disease. Working alongside NGOs, patient organizations, healthcare professionals, and local communities, the Foundation develops programs that help young people learn, grow, build relationships, and\u00a0participate fully in society despite the challenges they face.<\/p>\n

This ambition is reflected in partnerships such as the one with the Cerebral Palsy Foundation, which will help\u00a0improve early diagnosis of cerebral palsy in\u00a0nearly 1,000\u00a0children, with the goal of promoting early intervention, better care, and greater long-term independence. It is also\u00a0demonstrated\u00a0through the collaboration with AIDA, which will support up to\u00a01,600 young people during and after hospitalization to promote their well-being, inclusion, and\u00a0confidence in the future.<\/p>\n

Get the latest news
\n

\n delivered to your inbox<\/p>\n

Sign up for The Manila Times newsletters<\/p>\n

By signing up with an email address, I acknowledge that I have read and agree to the Terms of Service<\/a> and Privacy Policy<\/a>.<\/p>\n

At the same time, the Foundation continues its longstanding commitment to\u00a0humanitarian action and strengthening the resilience of vulnerable communities facing climate-related health risks. Since its\u00a0inception, its humanitarian efforts have reached more than 26 million patients in 45 countries, enabling the distribution of 128 million treatments through 177 humanitarian donations,\u00a0representing\u00a0more than 9 million medication packs. As part of its humanitarian commitment, it continues\u00a0to support the World Health Organization’s goal of\u00a0eliminating\u00a0sleeping sickness by 2030.<\/p>\n

To support this new phase of its development, the Sanofi Foundation is mobilizing an annual budget of \u20ac15\u00a0million for its programs\u00a0benefiting\u00a0children and young people,\u00a0while continuing its commitments in humanitarian action and climate\u00a0resilience.\u00a0Through this strengthened strategy,\u00a0the Sanofi Foundation\u00a0aims to have a positive impact on more than\u00a06 million children\u00a0and young people by 2030.<\/p>\n

\u00a0<\/p>\n

About\u00a0Sanofi<\/p>\n

Sanofi is an R&D driven, AI-powered biopharma company committed to improving people\u2019s lives and delivering compelling growth. We apply our deep understanding of the immune system to invent medicines and vaccines that treat and protect millions of people around the world, with an innovative pipeline that could benefit\u00a0millions more. Our team is guided by one purpose: we chase the miracles of science to improve people\u2019s lives; this inspires us to drive progress and deliver positive impact for\u00a0our people and the communities we serve, by addressing the most urgent healthcare, environmental, and societal challenges of our time. Sanofi is listed on EURONEXT: SAN and NASDAQ: SNY<\/p>\n

\u00a0\u00a0<\/p>\n

Media Relations\u00a0<\/p>\n

Sandrine\u00a0Guendoul\u00a0|\u00a0+33 6 25 09 14 25\u00a0|\u00a0[email\u00a0protected]<\/a><\/p>\n

L\u00e9o Le Bourhis\u00a0| +33 6 75 06 43 81 |\u00a0[email\u00a0protected]<\/a><\/p>\n

L\u00e9a Ubaldi\u00a0| +33 6 30 19 66 46 |\u00a0[email\u00a0protected]<\/a><\/p>\n

Laura\u00a0Romby| +33 6 74 16 74 29 |\u00a0[email\u00a0protected]<\/a><\/p>\n

Evan Berland\u00a0| +1 215 432 0234 |\u00a0[email\u00a0protected]<\/a><\/p>\n

Victor\u00a0Rouault\u00a0| +1 617 356 4751 |\u00a0[email\u00a0protected]<\/a><\/p>\n

Timothy Gilbert\u00a0| +1 516 521 2929 |\u00a0[email\u00a0protected]<\/a><\/p>\n

Ekaterina\u00a0Pesheva\u00a0| +1 410 926 6780 |\u00a0[email\u00a0protected]<\/a><\/p>\n

\u00a0<\/p>\n

Investor Relations<\/p>\n

Thomas Kudsk Larsen\u00a0|+ 44 7545 513 693 |\u00a0[email\u00a0protected]<\/a><\/p>\n

Aliz\u00e9 Kaisserian\u00a0| + 33 6 47 04 12 11 |\u00a0[email\u00a0protected]<\/a><\/p>\n

Keita Browne\u00a0| + 1 781 249 1766 |\u00a0[email\u00a0protected]<\/a><\/p>\n

Nathalie Pham\u00a0| + 33 7 85 93 30 17 |\u00a0[email\u00a0protected]<\/a><\/p>\n

Nina\u00a0Goworek\u00a0|\u00a0+1 908 569 7086\u00a0|\u00a0[email\u00a0protected]<\/a><\/p>\n

Thibaud Ch\u00e2telet\u00a0| + 33 6 80 80 89 90 |\u00a0[email\u00a0protected]<\/a><\/p>\n

Yun Li\u202f| +33 6 84 00 90 72 |\u202f[email\u00a0protected]<\/a><\/p>\n

Attachment<\/p>\n

\"\"<\/p>\n","protected":false},"excerpt":{"rendered":"Sanofi Foundation opens new chapter centered on future generations Paris, June 25, 2026.\u00a0The Sanofi Foundation is opening\u00a0a new…\n","protected":false},"author":2,"featured_media":41079,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[12983],"tags":[28239,28238,15364,7498,28240,849,2491,22842,1642,3687,13012],"class_list":["post-41078","post","type-post","status-publish","format-standard","has-post-thumbnail","category-sanofi","tag-centered","tag-chapter","tag-foundation","tag-future","tag-generations","tag-new","tag-on","tag-opens","tag-press","tag-release","tag-sanofi"],"_links":{"self":[{"href":"https:\/\/www.europesays.com\/france\/wp-json\/wp\/v2\/posts\/41078","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.europesays.com\/france\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.europesays.com\/france\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/france\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/france\/wp-json\/wp\/v2\/comments?post=41078"}],"version-history":[{"count":0,"href":"https:\/\/www.europesays.com\/france\/wp-json\/wp\/v2\/posts\/41078\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/france\/wp-json\/wp\/v2\/media\/41079"}],"wp:attachment":[{"href":"https:\/\/www.europesays.com\/france\/wp-json\/wp\/v2\/media?parent=41078"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.europesays.com\/france\/wp-json\/wp\/v2\/categories?post=41078"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.europesays.com\/france\/wp-json\/wp\/v2\/tags?post=41078"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}